Table 1.

Distribution of demographic and clinical comorbidity data in study cohorts.

Variables	ACO						p-value
	Statin
	All (N = 8,654)		No (N = 7,443)		Yes (N = 1,211)
	n	%	n	%	n	%
Age, years							<0.001***
<50	1,599	(18.5)	1,418	(19.1)	181	(15.0)
50–64	2,418	(27.9)	1,962	(26.4)	456	(37.7)
65+	4,637	(53.6)	4,063	(54.6)	574	(47.4)
Mean (SD)a	64.0	14.8	64.1	15.3	62.9	11.9	0.001**
Gender							<0.001***
Women	3,722	43.0	3,090	41.5	632	52.2
Men	4,932	57.0	4,353	58.5	579	47.8
Comorbidity
Sleep disorder	3,578	41.4	2,962	39.8	616	50.9	<0.001***
Diabetes	1,455	16.8	1,093	14.7	362	29.9	<0.001***
Hypertension	5,628	65.0	4,648	62.5	980	80.9	<0.001***
Hyperlipidemia	2,825	32.6	1,898	25.5	927	76.6	<0.001***
CAD	3,576	41.3	2,917	39.2	659	54.4	<0.001***
Stroke	1,415	16.4	1,205	16.2	210	17.3	<0.001***
Hepatitis B	326	3.77	281	3.78	45	3.72	0.92
Hepatitis C	135	1.56	116	1.56	19	1.57	0.98
Medication
Inhaled corticosteroids (ICSs)	2,064	23.9	1,743	23.4	321	26.5	0.02*
Oral steroids (OSs)	6,319	73.0	5,377	72.2	942	77.8	<0.001***

Chi-square test, ^a t-test.

*P < 0.05, **P < 0.01, ***P < 0.001.